|
RQCD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.641800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.569600E-04 |
| Normal-vs-Stage2 |
9.836900E-04 |
| Normal-vs-Stage3 |
2.597300E-04 |
| Normal-vs-Stage4 |
3.579800E-04 |
| Stage1-vs-Stage2 |
2.350000E-01 |
| Stage1-vs-Stage3 |
2.870600E-01 |
| Stage1-vs-Stage4 |
3.618400E-01 |
| Stage2-vs-Stage3 |
7.091200E-01 |
| Stage2-vs-Stage4 |
7.879400E-01 |
| Stage3-vs-Stage4 |
9.322400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.642000E-04 |
| Normal-vs-AfricanAmerican |
4.427400E-01 |
| Normal-vs-Asian |
8.429800E-04 |
| Caucasian-vs-AfricanAmerican |
9.163600E-02 |
| Caucasian-vs-Asian |
5.926600E-01 |
| AfricanAmerican-vs-Asian |
5.853700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.194080E-04 |
| Normal-vs-Female |
7.436600E-04 |
| Male-vs-Female |
2.566200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.378800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.13889999999273E-05 |
| Normal-vs-Age(61-80Yrs) |
1.237970E-03 |
| Normal-vs-Age(81-100Yrs) |
4.504300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.571350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.377200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.369000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.507400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.889000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.085800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.680400E-01 |
| Classical-VS-Follicular |
7.648400E-02 |
| Classical-VS-Other |
1.555020E-01 |
| Classical-VS-Normal |
2.858300E-03 |
| Tall-VS-Follicular |
7.295600E-01 |
| Tall-VS-Other |
3.661400E-01 |
| Tall-VS-Normal |
3.721700E-03 |
| Follicular-VS-Other |
5.542200E-01 |
| Follicular-VS-Normal |
1.553040E-04 |
| Other-VS-Normal |
7.523700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.36000000000325E-05 |
| Normal-vs-N1 |
1.63972999999151E-05 |
| N0-vs-N1 |
1.723620E-01 |
|
|
